Prime Healthcare Services Secures Credit Rating Upgrades from Fitch, Moody’s, and S&P

Prime Healthcare Achieves Credit Rating Upgrades from Fitch, Moody’s, and S&P, Reflecting Strong Financial and Operational Performance Prime Healthcare Services, Inc. has earned significant recognition from all three major credit rating agencies—Fitch Ratings, Moody’s Investors Service, and S&P Global Ratings—marking…

Read MorePrime Healthcare Services Secures Credit Rating Upgrades from Fitch, Moody’s, and S&P

Navitus Health Solutions Secures 2025-2026 Great Place to Work® Certification

Navitus Health Solutions Earns 2025-2026 Great Place To Work® Certification, Reflecting Strong Workplace Culture and Associate Engagement Navitus Health Solutions has officially announced that it has been Certified™ by Great Place To Work® for the 2025-2026 period—a recognition that underscores…

Read MoreNavitus Health Solutions Secures 2025-2026 Great Place to Work® Certification

Niemann-Pick Type C Market Outlook 2025-2035: Gene Editing & Personalized Medicine Drive Cure Research

Global Niemann-Pick Disease Type C (NPC) Market Outlook 2025–2035: Gene Editing, Personalized Medicine, and the Pursuit of a Cure The global Niemann-Pick Disease Type C (NPC) market is entering a transformative phase, driven by advances in gene therapy, personalized medicine,…

Read MoreNiemann-Pick Type C Market Outlook 2025-2035: Gene Editing & Personalized Medicine Drive Cure Research

Tenosynovitis Market Outlook 2025-2035: Biologics and Targeted Therapies Drive Growth

Global Tenosynovitis Market 2025–2035: Biologics and Targeted Therapies Drive Future Growth The global tenosynovitis market is entering a period of accelerated transformation, fueled by advancements in biologics, targeted therapies, and non-invasive treatment innovations. With a growing prevalence of inflammatory and…

Read MoreTenosynovitis Market Outlook 2025-2035: Biologics and Targeted Therapies Drive Growth

Lineage Cell Therapeutics Q2 2025 Results & Business Update

Lineage Cell Therapeutics Reports Second Quarter 2025 Results and Highlights Progress Across Multiple Clinical Programs Lineage Cell Therapeutics, a clinical-stage biotechnology company focused on developing novel allogeneic, or “off-the-shelf,” cell therapies for severe neurological and ophthalmic conditions, has announced its…

Read MoreLineage Cell Therapeutics Q2 2025 Results & Business Update

Southwell, Anthem Blue Cross Blue Shield Expand Pathway Network in South-Central Georgia

Anthem Blue Cross and Blue Shield of Georgia and Southwell Partner to Expand Pathway Network Coverage Across South-Central Georgia In a significant advancement for healthcare accessibility and affordability in South-Central Georgia, Anthem Blue Cross and Blue Shield of Georgia (Anthem)…

Read MoreSouthwell, Anthem Blue Cross Blue Shield Expand Pathway Network in South-Central Georgia

Oral Genome, Henry Schein Partner to Advance Dental-Medical Integration via Saliva Testing

Oral Genome and Henry Schein Join Forces to Drive Dental-Medical Integration with Point-of-Care Saliva Testing Oral Genome, a health technology innovator specializing in salivary diagnostics, has entered into a strategic partnership with Henry Schein, Inc., the world’s largest provider of…

Read MoreOral Genome, Henry Schein Partner to Advance Dental-Medical Integration via Saliva Testing